Winning Health Technology Group Co., Ltd. (SHE:300253)
China
· Delayed Price · Currency is CNY 8.54
+0.14 (1.67%)
Apr 29, 2026, 3:14 PM CST
SHE:300253 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 18,491 | 19,407 | 15,552 | 15,340 | 21,932 | 35,967 | Upgrade
|
| Market Cap Growth | -21.35% | 24.79% | 1.39% | -30.06% | -39.02% | -3.68% | Upgrade
|
| Enterprise Value | 18,008 | 19,283 | 15,864 | 15,636 | 22,047 | 35,906 | Upgrade
|
| Last Close Price | 8.40 | 8.82 | 7.15 | 7.15 | 10.22 | 16.62 | Upgrade
|
| PE Ratio | - | - | 176.95 | 42.85 | 201.88 | 95.11 | Upgrade
|
| Forward PE | 55.53 | 44.19 | 25.54 | 34.44 | 171.33 | 46.38 | Upgrade
|
| PS Ratio | 8.57 | 9.22 | 5.59 | 4.85 | 7.09 | 13.08 | Upgrade
|
| PB Ratio | 3.31 | 3.47 | 2.62 | 2.70 | 4.28 | 6.95 | Upgrade
|
| P/TBV Ratio | 4.87 | 5.20 | 3.57 | 3.78 | 5.47 | 10.21 | Upgrade
|
| P/FCF Ratio | 52.62 | 57.93 | 152.91 | - | - | 439.53 | Upgrade
|
| P/OCF Ratio | 34.73 | 34.95 | 38.16 | 83.01 | 218.36 | 97.72 | Upgrade
|
| EV/Sales Ratio | 8.34 | 9.15 | 5.70 | 4.94 | 7.13 | 13.06 | Upgrade
|
| EV/EBITDA Ratio | - | - | 54.11 | 37.49 | 242.55 | 120.01 | Upgrade
|
| EV/EBIT Ratio | - | - | 58.70 | 39.56 | 317.02 | 128.54 | Upgrade
|
| EV/FCF Ratio | 51.25 | 57.56 | 155.97 | - | - | 438.79 | Upgrade
|
| Debt / Equity Ratio | 0.20 | 0.21 | 0.19 | 0.19 | 0.20 | 0.18 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 3.67 | 2.53 | 9.60 | 3.00 | Upgrade
|
| Debt / FCF Ratio | 3.24 | 3.43 | 11.12 | - | - | 11.44 | Upgrade
|
| Net Debt / Equity Ratio | -0.08 | -0.11 | -0.04 | 0.00 | -0.05 | -0.13 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.88 | 3.00 | -0.71 | -0.04 | -2.70 | -2.22 | Upgrade
|
| Net Debt / FCF Ratio | -1.35 | -1.83 | -2.04 | 0.12 | 1.10 | -8.11 | Upgrade
|
| Asset Turnover | 0.26 | 0.24 | 0.32 | 0.39 | 0.40 | 0.41 | Upgrade
|
| Inventory Turnover | 13.11 | 13.38 | 14.63 | 16.72 | 15.11 | 11.29 | Upgrade
|
| Quick Ratio | 3.00 | 2.72 | 2.95 | 2.70 | 2.60 | 3.11 | Upgrade
|
| Current Ratio | 3.13 | 2.83 | 3.10 | 2.84 | 2.73 | 3.28 | Upgrade
|
| Return on Equity (ROE) | -6.60% | -6.66% | 0.86% | 5.88% | 0.29% | 7.16% | Upgrade
|
| Return on Assets (ROA) | -2.01% | -1.62% | 1.95% | 3.02% | 0.57% | 2.58% | Upgrade
|
| Return on Invested Capital (ROIC) | -5.38% | -4.19% | 2.73% | 6.99% | 0.57% | 6.30% | Upgrade
|
| Return on Capital Employed (ROCE) | -4.00% | -3.30% | 3.80% | 5.80% | 1.10% | 4.50% | Upgrade
|
| Earnings Yield | -1.97% | -1.93% | 0.56% | 2.33% | 0.50% | 1.05% | Upgrade
|
| FCF Yield | 1.90% | 1.73% | 0.65% | -0.84% | -1.02% | 0.23% | Upgrade
|
| Dividend Yield | 0.17% | - | 0.21% | 0.28% | 0.10% | 0.12% | Upgrade
|
| Payout Ratio | - | - | 62.50% | 7.32% | 42.03% | 14.88% | Upgrade
|
| Buyback Yield / Dilution | -2.05% | -2.32% | 1.60% | -2.42% | 0.22% | -0.44% | Upgrade
|
| Total Shareholder Return | -1.88% | -2.32% | 1.81% | -2.14% | 0.32% | -0.32% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.